AstraZeneca, Human Longevity, Genomics England, Wellcome Trust, University of Helsinki, Montreal Heart Institute deal

AstraZeneca will collaborate with Human Longevity, Genomics England and several academic organizations to collect 2 million genomes over 10 years using next-generation sequencing. Additionally, AZ is launching an internal genomics research center in Cambridge, U.K., to combine data from past and future trials with associated phenotype information. Human Longevity will sequence and analyze up to 500,000 samples from AZ’s own trials. In return, AZ will receive access to Human Longevity’s database of integrated genomic, clinical, molecular and health record data, which is designed to have 1 million patient records by 2020. ...